Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Related Citations for PubMed (Select 24899248)

1.

Potential prognostic and diagnostic application of a novel monoclonal antibody against keratinocyte growth factor receptor.

Ceccarelli S, Bei R, Vescarelli E, D'Amici S, di Gioia C, Modesti A, Romano F, Redler A, Marchese C, Angeloni A.

Mol Biotechnol. 2014 Oct;56(10):939-52. doi: 10.1007/s12033-014-9773-x.

2.

99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 tetravalent single-chain Fv monoclonal antibody .

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Jun 26 [updated 2007 Dec 28].

3.

Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells.

Rotolo S, Ceccarelli S, Romano F, Frati L, Marchese C, Angeloni A.

PLoS One. 2008 Jun 25;3(6):e2528. doi: 10.1371/journal.pone.0002528.

4.

Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.

Ning S, Shui C, Khan WB, Benson W, Lacey DL, Knox SJ.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):177-87.

PMID:
9422575
5.
6.

Expression of keratinocyte growth factor receptor correlates with expansive growth and early stage of gastric cancer.

Matsunobu T, Ishiwata T, Yoshino M, Watanabe M, Kudo M, Matsumoto K, Tokunaga A, Tajiri T, Naito Z.

Int J Oncol. 2006 Feb;28(2):307-14.

PMID:
16391783
7.

Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells.

Yoshino M, Ishiwata T, Watanabe M, Matsunobu T, Komine O, Ono Y, Yamamoto T, Fujii T, Matsumoto K, Tokunaga A, Naito Z.

Int J Oncol. 2007 Oct;31(4):721-8.

PMID:
17786302
8.

99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 divalent single-chain Fv monoclonal antibody .

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Jun 19 [updated 2008 Jan 28].

9.

Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line.

Capone A, Visco V, Belleudi F, Marchese C, Cardinali G, Bellocci M, Picardo M, Frati L, Torrisi MR.

Cell Growth Differ. 2000 Nov;11(11):607-14.

10.

Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.

Cho K, Matsuda Y, Ueda J, Uchida E, Naito Z, Ishiwata T.

Int J Oncol. 2012 Apr;40(4):1040-8. doi: 10.3892/ijo.2011.1280. Epub 2011 Dec 6.

11.

Monoclonal antibodies against human breast tumor-associated antigens: characterization of B21 antigen.

Annibali NV, San Martino JA, Baldi A.

J Natl Cancer Inst. 1994 Feb 2;86(3):215-21.

PMID:
8283494
12.

Ligand-induced clathrin-mediated endocytosis of the keratinocyte growth factor receptor occurs independently of either phosphorylation or recruitment of eps15.

Belleudi F, Visco V, Ceridono M, Leone L, Muraro R, Frati L, Torrisi MR.

FEBS Lett. 2003 Oct 23;553(3):262-70.

PMID:
14572635
13.

[Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].

Hong B, Qian Y, Yao HP.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013 Sep;42(5):511-6. Chinese.

PMID:
24167131
14.

Characterization of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.

Udayachander M, Meenakshi A, Sivakumar N, Kumar RR, Shankar SG, Dean CJ, Modjtahedi H.

Hum Antibodies. 1999;9(3):149-54.

PMID:
10690627
15.

64Cu-DOTA hu4D5v8 (scFv-CH2-CH3)2.

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Apr 11 [updated 2008 Apr 03].

16.

[Preparation, characterization and potential application of monoclonal antibody 18A4 against AGR2].

Wu ZH, Zhu Q, Gao GW, Zhou CC, Li DW.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Jan;26(1):49-51. Chinese.

PMID:
20056089
17.

HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic.

Belleudi F, Leone L, Purpura V, Cannella F, Scrofani C, Torrisi MR.

Oncogene. 2011 Dec 15;30(50):4963-76. doi: 10.1038/onc.2011.203. Epub 2011 May 30.

PMID:
21625213
18.

Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer.

Kurban G, Ishiwata T, Kudo M, Yokoyama M, Sugisaki Y, Naito Z.

Oncol Rep. 2004 May;11(5):987-91.

PMID:
15069536
19.

Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer.

Hackett J, Xiao Z, Zang XP, Lerner ML, Brackett DJ, Brueggemeier RW, Li PK, Pento JT.

Anticancer Res. 2007 Nov-Dec;27(6B):3801-6.

20.

Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer.

Ishiwata T, Friess H, B├╝chler MW, Lopez ME, Korc M.

Am J Pathol. 1998 Jul;153(1):213-22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk